Linqiang Lai
Lishui, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
An integrated multimodal model for early prediction of high-risk recurrence phenotype indicative of poor disease-free survival in stage IA NSCLC: a multicenter study.
Journal: Frontiers in immunology
Published: June 22, 2026
Bronchial Arterial Chemoembolization with versus without Anlotinib in Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Case-Control Study.
Journal: Clinical interventions in aging
Published: December 16, 2025
Prediction of Early Recurrence After Bronchial Arterial Chemoembolization in Non-small Cell Lung Cancer Patients Using Dual-energy CT: An Interpretable Model Based on SHAP Methodology.
Journal: Academic radiology
Published: May 19, 2025
CT radiomics approach to predict response to bronchial arterial chemoembolization in advanced lung cancer by multicenter study.
Journal: Scientific reports
Published: May 11, 2025
Bronchial arterial chemoembolization with Drug-Eluting beads plus sequential chemotherapy for the treatment of stage III and IV lung squamous cell carcinoma.
Journal: European journal of radiology
Published: October 25, 2023
Machine Learning Classifier for Preoperative Prediction of Early Recurrence After Bronchial Arterial Chemoembolization Treatment in Lung Cancer Patients.
Journal: Academic radiology
Published: March 04, 2023
A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
Journal: Frontiers in molecular biosciences
Published: February 01, 2021
Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: July 16, 2020
Iodine-125 Brachytherapy Can Prolong Progression-Free Survival of Patients with Locoregional Recurrence and/or Residual Hepatocellular Carcinoma After Radiofrequency Ablation.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: June 20, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026